Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Morbidity after sentinel lymph node biopsy in primary breast cancer evaluated
September 1st, 2005
Researchers evaluated the level of morbidity after sentinel lymph node biopsy (SLNB) in primary breast cancer patients. "Axillary lymph node dissection (ALND) as part of surgical treatment for patients with breast cancer is associated with significant morbidity. SLNB is a newly developed method of staging the axilla and has the potential to avoid an ALND in lymph node-negative patients, thereby minimizing morbidity. The aim of this study was to investigate physical and psychological morbidity after SLNB in the treatment of early breast cancer in a randomized controlled trial," scientists in England reported. "Between November 1999 and February 2003,...
Source: Women's Health Weekly (2005-09-01)
|
